Do long-term patient-reported outcomes improve similarly in psoriatic arthritis and axial spondyloarthritis patients treated with secukinumab? Results from the EuroSpA collaboration
16/11/2023
Pons M, Horskjær Rasmussen S, Nysom Christiansen S, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft A, Rotar Z, Perdan Pirkmajer K, Nissen M, Moeller B, Macfarlane G, Jones G, Iannone F, Caporali R, Laas K, Vorobjov S, Di Giuseppe D, Nihan Coskun B, Yagiz B, Provan S, Fagerli K, Castrejon I, Otero-Valera L, van de Sande M, van der Horst-Bruinsma I, Nordstrom D, Kuusalo L, Vieira-Sousa E, Bernardes M, Olofsson T, Baranová J, Hetland M, Østergaard M, Ørnbjerg L.
ACR 2023
Pons M, Horskjær Rasmussen S, Nysom Christiansen S, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft A, Rotar Z, Perdan Pirkmajer K, Nissen M, Moeller B, Macfarlane G, Jones G, Iannone F, Caporali R, Laas K, Vorobjov S, Di Giuseppe D, Nihan Coskun B, Yagız B, Provan S, Fagerli K, Castrejon I, Otero-Valera L, van de Sande M, van der Horst-Bruinsma I, Nordstrom D, Kuusalo L, Vieira-Sousa E, Bernardes M, Olofsson T, Baranová J, Hetland M, Østergaard M, Ørnbjerg L. Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/do-long-term-patient-reported-outcomes-improve-similarly-in-psoriatic-arthritis-and-axial-spondyloarthritis-patients-treated-with-secukinumab-results-from-the-eurospa-collaboration/.
https://acrabstracts.org/abstract/do-long-term-patient-reported-outcomes-improve-similarly-in-psoriatic-arthritis-and-axial-spondyloarthritis-patients-treated-with-secukinumab-results-from-the-eurospa-collaboration/